Stock Price, News, Quote and Profile of IMMUNOPRECISE ANTIBODIES LTD(NASDAQ:IPA) stock

IMMUNOPRECISE ANTIBODIES LTD

NASDAQ:IPA (1/3/2025, 8:00:02 PM)

After market: 0.5098 -0.01 (-1.94%)

0.5199

+0.07 (+15.53%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorHealth Care

GICS IndustryLife Sciences Tools & Services

GICS SubIndustryLife Sciences Tools & Services

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Chartmill High Growth Momentum

EPS Q2Q%0.87%

Sales Q2Q%3.39%

CRS5.29

6 Month-48.01%

Overview

Earnings (Last)12-10 2024-12-10/bmo

Earnings (Next)N/A N/A

Ins Owners1.34%

Inst Owners6.07%

Market Cap14.99M

Shares28.83M

PEN/A

Fwd PEN/A

Dividend YieldN/A

Analysts80

Short Float %0.59%

Short Ratio0.24

IPO01-30 1987-01-30

Stock Screener Links

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The company is headquartered in Victoria, British Columbia. The firm owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. The company has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The firm utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.